StockData
Iovance Biotherapeutics, Inc. logo

Iovance Biotherapeutics, Inc. (IOVA) stock

IOVANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3087% above fair value
$7.48−0.05 (-0.66%)

Close on Nov 18, 2026Market cap $3.39BP/E –Yield –

Iovance Biotherapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Iovance Biotherapeutics's market cap was $3.66B on Nov 11, 2026, against $952.09M a year earlier. Over the last 5 years it ranged from $574.37M to $6.71B, with a median of $1.69B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.66B+248.2%
2025Dec 31, 2025$1.05B-53.3%
2024Dec 31, 2024$2.25B+8.4%
2023Dec 29, 2023$2.08B+106.2%
2022Dec 30, 2022$1.01B-66.3%
2021Dec 31, 2021$2.99B-56.0%
2020Dec 31, 2020$6.80B+94.7%
2019Dec 31, 2019$3.49B+305.1%
2018Dec 31, 2018$862.22M+49.8%
2017Dec 29, 2017$575.64M+33.7%
2016Dec 30, 2016$430.54M+16.7%
2015Dec 31, 2015$369.07M+69.7%
2014Dec 31, 2014$217.52M+37.4%
2013Dec 31, 2013$158.27M+818.8%
2012Dec 31, 2012$17.22M-76.6%
2011Dec 30, 2011$73.64M–

More Iovance Biotherapeutics figures

See a number that looks wrong?